Related Experiment Video
Updated: Jan 9, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Barriers and facilitators to nicotine and cannabis vaping cessation among young adults: a qualitative study using
Nhung Nguyen1,2,3, Jason M Satterfield3, Salomeh Keyhani4
1HEARTY Lab, University of California, San Francisco, San Francisco, CA, 94158, United States.
Background:
Despite young adults' growing use of nicotine and cannabis vaporized products (vaping), little is known about factors influencing vaping cessation.
Purpose:
Identify barriers and facilitators to nicotine and/or cannabis vaping cessation among young adults (18-29 years old).
Methods:
We conducted a thematic analysis of interviews with 20 California young adults (mean age = 22.8, racially and ethnically diverse) who vaped nicotine and/or cannabis (specifically delta-9-tetrahydrocannabinol or THC) in 2024-2025. We mapped cessation-related barriers and facilitators to Capability, Opportunity, Motivation, and Behavior model and Theoretical Domains Framework.
Results:
Young adults expressed stronger motivation to stop vaping nicotine than cannabis. Psychological Capability barriers involved a lack of self-control over nicotine vaping. Physical Opportunity factors, such as product accessibility and treatment unaffordability, hindered quitting, while the cost burden of vaporized products was a facilitator. Social Opportunity included both barriers (ie, socialization) and facilitators (ie, protection of loved ones or relationships). Automatic Motivation barriers included habitual use and addiction, while negative emotion toward vaping harms facilitated quitting. Reflective Motivation included the most identified factors for barriers (eg, low perceived risk of vaping, coping with mental health, and personal identity linked to vaping) and facilitators (eg, quitting desire and concerns about health and vaporized product quality). Most factors influencing vaping cessation overlapped for nicotine and cannabis. Substance-specific barriers for nicotine (ie, self-control, oral fixation, and flavor appeal) and cannabis (ie, perceived benefits) were identified.
Conclusions:
Findings provide insights into potential targets for future interventions to help young adults quit vaping nicotine and/or cannabis.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Abuse and Addiction: Pharmacological Phenomena
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...